These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 8489408

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls.
    Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K.
    Brain; 2000 Jun; 123 ( Pt 6)():1155-60. PubMed ID: 10825354
    [Abstract] [Full Text] [Related]

  • 6. IBZM-SPECT imaging in Parkinson's disease. Quantification of binding ratios from sequential SPECT measurements in patients and controls.
    Cordes M, Hierholzer J, Schelosky L, Poewe W, Cordes I, Horowski R, Eichstaedt H, Schmidt D, Felix R.
    Adv Neurol; 1993 Jun; 60():525-8. PubMed ID: 8420183
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. 123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's disease.
    Wenning GK, Donnemiller E, Granata R, Riccabona G, Poewe W.
    Mov Disord; 1998 May; 13(3):438-45. PubMed ID: 9613734
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Alterations of striatal dopamine D2 receptors contribute to deteriorated response to L-dopa in Parkinson's disease: a [123I]-IBZM SPET study.
    Pizzolato G, Chierichetti F, Rossato A, Cagnin A, Fabbri M, Dam M, Ferlin G, Battistin L.
    J Neural Transm Suppl; 1995 May; 45():113-22. PubMed ID: 8748616
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lateralized differences in iodine-123-IBZM uptake in the basal ganglia in asymmetric Parkinson's disease.
    Knable MB, Jones DW, Coppola R, Hyde TM, Lee KS, Gorey J, Weinberger DR.
    J Nucl Med; 1995 Jul; 36(7):1216-25. PubMed ID: 7790947
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dopamine D2 receptor imaging with iodine-123-iodobenzamide SPECT in idiopathic rotational torticollis.
    Hierholzer J, Cordes M, Schelosky L, Richter W, Keske U, Venz S, Semmler W, Poewe W, Felix R.
    J Nucl Med; 1994 Dec; 35(12):1921-7. PubMed ID: 7989970
    [Abstract] [Full Text] [Related]

  • 17. Correlation of clinical response in apomorphine test with D2-receptor status as demonstrated by 123I IBZM-SPECT.
    Schelosky L, Hierholzer J, Wissel J, Cordes M, Poewe W.
    Mov Disord; 1993 Oct; 8(4):453-8. PubMed ID: 8232354
    [Abstract] [Full Text] [Related]

  • 18. Regional analysis of D2 dopamine receptors in Parkinson's disease using SPECT and iodine-123-iodobenzamide.
    Nadeau SE, Couch MW, Devane CL, Shukla SS.
    J Nucl Med; 1995 Mar; 36(3):384-93. PubMed ID: 7884499
    [Abstract] [Full Text] [Related]

  • 19. Estimation of dopamine D2 receptor binding potential in the striatum with iodine-123-IBZM SPECT: technical and interobserver variability.
    Verhoeff NP, Kapucu O, Sokole-Busemann E, van Royen EA, Janssen AG.
    J Nucl Med; 1993 Dec; 34(12):2076-84. PubMed ID: 8254390
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.